Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients

Summary

Patients at least 18 years of age will be enrolled in the study to assess the efficacy and tolerability of Picato gel in the treatment of molluscum contagiosum. Patients must have an immunocompromised condition due to taking immunosuppressive drugs or having an inherited disease affecting the immune system.

Timeline

Start

2017-12-20

Primary completion

2018-09-08

Completion

2018-10-16

Drugs

Indications